Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS

MLA

José Boucraut, et al. Combination of Serum and CSF Neurofilament-Light and Neuroinflammatory Biomarkers to Evaluate ALS. Jan. 2021. EBSCOhost, https://doi.org/10.1038/s41598-020-80370-6⟩.

APA

José Boucraut, Emilien Delmont, Annie Verschueren, Shahram Attarian, Amandine Parlanti, Alexandre Brodovitch, & Aude-Marie Grapperon. (2021). Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS. https://doi.org/10.1038/s41598-020-80370-6⟩

Chicago

José Boucraut, Emilien Delmont, Annie Verschueren, Shahram Attarian, Amandine Parlanti, Alexandre Brodovitch, and Aude-Marie Grapperon. 2021. “Combination of Serum and CSF Neurofilament-Light and Neuroinflammatory Biomarkers to Evaluate ALS,” January. doi:10.1038/s41598-020-80370-6⟩.